EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report

Amro Nagy, Muhammad Yaqut, Doaa Abbas, Amna Mohamed

Oman Medical Journal · 31.07.2026 · 41 (4) · e864-e864

DOI: 10.5001/omj.2026.10 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oman Medical Journal, online erschienen am 31.07.2026. Verfasst von Amro Nagy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Sultan Qaboos Comprehensive Cancer Care, Muscat, Oman. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 160 cases of subacute thyroiditis (SAT) following COVID-19 vaccination or infection have been reported in the literature. Roughly one-half were attributed to either the first or second dose of the COVID-19 vaccine. We report a rare case of SAT in a 47-year-old male patient with a history of clear cell renal cell carcinoma and advanced chronic kidney disease, among other comorbidities, excluding thyroid disease. After he received the third dose of the Pfizer mRNA vaccine, a deranged thyroid profile was accidentally discovered. His SAT remained asymptomatic and normalized in about six months without treatment. SAT post-COVID vaccination is a self-limiting and rare condition that should be considered in the differential diagnosis of silent thyroiditis.

Schlagwörter

Stichwörter der Autor:innen

ASIA SyndromeCOVID-19OmanPfizer-BioNTech COVID-19 VaccineSubacute ThyroiditismRNA Vaccines

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Sultan Qaboos Comprehensive Cancer Care, Muscat, Oman.
  • Department of Medical Oncology, Sultan Qaboos Comprehensive Cancer Care, Muscat, Oman.
  • Department of Pharmacy, Sultan Qaboos Comprehensive Cancer Care, Muscat, Oman.

Zitieren

APA

Nagy, A., Yaqut, M., Abbas, D., & Mohamed, A. (2026). Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report. Oman Medical Journal, 41(4), e864-e864. https://doi.org/10.5001/omj.2026.10

Vancouver

Nagy A, Yaqut M, Abbas D, Mohamed A. Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report. Oman Medical Journal. 2026;41(4):e864-e864. doi:10.5001/omj.2026.10

BibTeX
@article{Nagy2026,
  author = {Nagy, Amro and Yaqut, Muhammad and Abbas, Doaa and Mohamed, Amna},
  title = {Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report},
  journal = {Oman Medical Journal},
  year = {2026},
  volume = {41},
  number = {4},
  pages = {e864--e864},
  doi = {10.5001/omj.2026.10}
}
Kostenlos starten →